We are live on
!
Find out more
KKRC
Kohlberg Kravis Roberts & Co Portfolio holdings
AUM
$5.35B
1-Year Est. Return
63.01%
This Fund
S&P 500
This Quarter
Est. Return
+10.15%
1 Year Est. Return
+63.01%
3 Year Est. Return
+297.95%
5 Year Est. Return
+219.08%
10 Year Est. Return
+856.54%
AUM
$8.12B
AUM Growth
+$1.54B
(+24%)
Cap. Flow
+$816M
Cap. Flow
% of AUM
10.05%
Top 10 Holdings %
Top 10 Hldgs %
85.43%
Holding
58
New
3
Increased
2
Reduced
–
Closed
3
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
BridgeBio Pharma
BBIO
|
+$1.01B |
| 2 |
BDXA
Becton, Dickinson and Company Depositary Shares, each Representing a 1/20th Interest in a Share of 6
BDXA
|
+$25.8M |
| 3 |
SRCL
Stericycle Inc
SRCL
|
+$25.1M |
| 4 |
DCUE
Dominion Energy, Inc. 2019 Series A Corporate Units
DCUE
|
+$12.5M |
| 5 |
NEE.PRR
NextEra Energy, Inc.
NEE.PRR
|
+$10.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
GHY
PGIM Global High Yield Fund
GHY
|
+$8.77M |
| 2 |
JRO
Nuveen Floating Rate Income Opportunty Fund
JRO
|
+$2.29M |
| 3 |
Lear
LEA
|
+$260K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 44.07% |
| 2 | Healthcare | 13.14% |
| 3 | Technology | 9.97% |
| 4 | Financials | 6.13% |
| 5 | Real Estate | 5.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
QHC
26
DELISTED
Quorum Health Corporation
QHC
| $4.15M | 0.05% |
2,988,781
| – | – |
|
|
WW
27
DELISTED
WW International
WW
| $1.91M | 0.02% |
100,000
| – | – |
|
28
Dave & Buster's
PLAY
$357M
| $1.21M | 0.02% |
30,000
| – | – |
|
29
Ares Capital
ARCC
$13.4B
| $1.04M | 0.01% |
58,000
| – | – |
|
30
United Rentals
URI
$65.7B
| $1.01M | 0.01% |
7,600
| – | – |
|
|
LOGM
31
DELISTED
LogMein, Inc.
LOGM
| $1.01M | 0.01% |
13,676
| – | – |
|
|
MRC
32
DELISTED
MRC Global
MRC
| $993K | 0.01% |
58,000
| – | – |
|
|
SQBG
33
DELISTED
Sequential Brands Group, Inc.
SQBG
| $407K | 0.01% |
18,519
| – | – |
|
|
VRS
34
DELISTED
Verso Corporation
VRS
| $191K | ﹤0.01% |
10,023
| – | – |
|
|
GHY
35
PGIM Global High Yield Fund
GHY
$476M
| – | – |
-629,266
| Closed | -$8.77M |
|
|
36
Lear
LEA
$7.39B
| – | – |
-1,916
| Closed | -$260K |
|
|
JRO
37
DELISTED
Nuveen Floating Rate Income Opportunty Fund
JRO
| – | – |
-238,225
| Closed | -$2.29M |
|
Similar funds
DPL
LP
ENV
CBUSF
WL
DRZID
FMWA
SDIC
Kohlberg Kravis Roberts & Co's Q2 2019 Portfolio in Review
As of Q2 2019, Kohlberg Kravis Roberts & Co held 58 positions worth $8.12B, up 24% from $6.57B the previous quarter. Its ten largest holdings account for 85% of the portfolio.
Kohlberg Kravis Roberts & Co deployed $816M of net new capital in Q2 2019, opening 3 new positions and adding to 2 existing holdings. Its largest new stake was BridgeBio Pharma: 36,900,661 shares worth $995M.
By sector, the portfolio is most concentrated in Industrials at 44% of assets, up from 43% a quarter earlier, followed by Healthcare and Technology.
On the sell side, the most notable exit was PGIM Global High Yield Fund, an estimated $8.77M sold.
- Kohlberg Kravis Roberts & Co's largest Q2 2019 buy was BridgeBio Pharma: 36,900,661 shares worth $995M.
- Kohlberg Kravis Roberts & Co added most to Becton, Dickinson and Company Depositary Shares, each Representing a 1/20th Interest in a Share of 6 in Q2 2019, an estimated $25.8M increase.
- Kohlberg Kravis Roberts & Co fully exited PGIM Global High Yield Fund in Q2 2019, selling an estimated $8.77M.
- Kohlberg Kravis Roberts & Co's ten largest holdings make up 85% of its $8.12B portfolio in Q2 2019.
- Kohlberg Kravis Roberts & Co opened 3 new positions and closed 3 in Q2 2019.
- Kohlberg Kravis Roberts & Co's portfolio value rose 24% quarter-over-quarter to $8.12B.
Based on Kohlberg Kravis Roberts & Co's 13F filing for Q2 2019, filed 14 Aug 2019.